A STROBE cohort study of 755 deep and superficial upper-extremity vein thrombosis.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Feb 2020
Historique:
entrez: 7 2 2020
pubmed: 7 2 2020
medline: 18 2 2020
Statut: ppublish

Résumé

Upper extremity vein thrombosis (UE-VT) are more and more frequent pathologies and yet little studied. The aim is to describe the clinical and ultrasound features, UE-VT-related diseases, and the prevalence of pulmonary embolism (PE) and associated deaths.All UE-VT patients diagnosed by Doppler-ultrasound in Nantes University Hospital, from January 2015 to December 2017, were included retrospectively. UE-VT suspicion patterns, clinical features, UE-VT topography, and prevalence of PE and death were analyzed.Seven hundred and fifty-five UE-VT were analyzed, including 427 deep thrombosis (UE-DVT) and 328 superficial thrombosis (UE-SVT). In 86.2% (n = 651) UE-VT were related to endovascular devices. Among these thrombosis, one third is in connection with a PICC LINE and one quarter with a peripheral venous line. Forty nine percent (n = 370) of the patients had solid neoplasia or hematological malignancies. An inflammatory or systemic infectious context was found in 40.8% (n = 308) of the cases. The most frequently observed clinical sign at the UE-VT diagnosis was edema (28.6%). Among the UE-SVT it was the presence of an indurated cord (33.2%) and among the UE-DVT the indication of the Doppler-ultrasound was mainly a suspicion of infection on endovascular device (35.1%). In 10.6% (n = 80) of the cases the UE-VT were asymptomatic. The most frequently thrombosed veins were brachial basilic veins (16.7% of all thrombosed segments) followed by jugular (13%) and subclavian (12.3%) veins; 61.3% (n = 463) of UE-VT were in the right upper extremity; 63.3% (n = 478) UE-VT were occlusive. The occurrence of PE is 4% and the death rate is 10.2%, mainly related to the severe comorbidities of patients with UE-VT.UE-VT occurs in particular clinical contexts (hematological malignancies, solid cancers, systemic infections) and in the majority of endovascular devices (86.2%). The occurrence of PE is low.

Identifiants

pubmed: 32028410
doi: 10.1097/MD.0000000000018996
pii: 00005792-202002070-00027
pmc: PMC7015650
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e18996

Références

J Cardiovasc Electrophysiol. 2004 Nov;15(11):1258-62
pubmed: 15574174
Chest. 2008 Jan;133(1):143-8
pubmed: 17925416
Lancet. 2013 Jul 27;382(9889):311-25
pubmed: 23697825
Blood Coagul Fibrinolysis. 1999 Dec;10(8):455-7
pubmed: 10636455
Lancet. 1999 Apr 24;353(9162):1386-9
pubmed: 10227218
Thromb Haemost. 2008 Sep;100(3):440-6
pubmed: 18766260
N Engl J Med. 2010 Sep 23;363(13):1222-32
pubmed: 20860504
J Thromb Haemost. 2015 Dec;13(12):2155-60
pubmed: 26340226
Clin Hemorheol Microcirc. 2009;41(4):279-85
pubmed: 19318721
Eur J Vasc Surg. 1988 Jun;2(3):161-5
pubmed: 3410064
Arch Intern Med. 2000 Feb 14;160(3):382-6
pubmed: 10668841
Haematologica. 2019 Jan;104(1):e29-e31
pubmed: 30076179
Circulation. 2004 Aug 3;110(5):566-70
pubmed: 15262837
Rev Med Interne. 2019 Jan;40(1):9-15
pubmed: 30122260
Harefuah. 2011 Nov;150(11):849-51, 875
pubmed: 22428206
Semin Thromb Hemost. 2002 Feb;28(1):89-99
pubmed: 11885029
Exp Clin Cardiol. 2013 Spring;18(2):129-38
pubmed: 23940438
J Vasc Surg. 2005 Mar;41(3):476-8
pubmed: 15838483
J Vasc Surg. 2010 Jun;51(6):1538-47
pubmed: 20304578
Clin Appl Thromb Hemost. 2017 Oct;23(7):748-754
pubmed: 27572888
J Thromb Haemost. 2011 Feb;9(2):312-9
pubmed: 21040443
Clin Infect Dis. 2002 May 1;34(9):1179-83
pubmed: 11941543
Rev Med Suisse. 2015 Feb 4;11(460):342, 344-7
pubmed: 25854043
J Thromb Haemost. 2008 Aug;6(8):1269-74
pubmed: 18445117
Thromb Res. 2016 Apr;140 Suppl 1:S81-8
pubmed: 27067985
Cochrane Database Syst Rev. 2017 Dec 11;12:CD012175
pubmed: 29226949
BMJ Open. 2015 Oct 06;5(10):e008213
pubmed: 26443651
J Thromb Haemost. 2005 Nov;3(11):2471-8
pubmed: 16241945
J Thromb Haemost. 2010 Nov;8(11):2483-93
pubmed: 20735729
Circulation. 2012 Aug 7;126(6):768-73
pubmed: 22869858
Thromb Res. 2018 Jun;166:92-95
pubmed: 29704767
Fertil Steril. 2009 Aug;92(2):620-5
pubmed: 18710711
J Vasc Surg Venous Lymphat Disord. 2015 Jul;3(3):243-50.e1
pubmed: 26992301
Ann Vasc Surg. 2012 Oct;26(7):964-72
pubmed: 22749742

Auteurs

Gaetan Ploton (G)

Department of Internal and Vascular Medicine.

Marc-Antoine Pistorius (MA)

Department of Internal and Vascular Medicine.

Alizée Raimbeau (A)

Department of Internal and Vascular Medicine.

Julien Denis Le Seve (J)

Department of Internal and Vascular Medicine.

Guillaume Bergère (G)

Department of Internal and Vascular Medicine.

Chan Ngohou (C)

Department of Medical Information, CHU Nantes.

Yann Goueffic (Y)

Department of Vascular Surgery, University Hospital of Nantes, France.

Mathieu Artifoni (M)

Department of Internal and Vascular Medicine.

Cécile Durant (C)

Department of Internal and Vascular Medicine.

Giovanni Gautier (G)

Department of Internal and Vascular Medicine.

Jérôme Connault (J)

Department of Internal and Vascular Medicine.

Olivier Espitia (O)

Department of Internal and Vascular Medicine.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH